The Clinical Trials Activity – Rare Cancers, Rare Diseases and Unmet Need (RCRDUN)) Initiative aims to enable or support:

• New opportunities for clinical trial participation and associated benefits from accessing the latest research by members of the Australian community living with a medical condition for which there are limited effective treatment options.
• Attention given to under-researched health priorities and conditions, such as rare cancers and rare diseases.
• Deployment of innovative trial designs and recruitment strategies to provide high-quality evidence of the efficacy of new health treatments, drugs and devices.
• Purposeful health service engagement to improve the translation of research into practice and improve outcomes for patients.
• Implementation of new health treatments, drugs and devices to improve health and wellbeing.
• Reinforcement of Australia’s position as a preferred destination for clinical trials.

RCRDUN Initiative grant opportunities

The MRFF is seeking applications for the following areas:

• Reproductive Cancers
• Childhood Brain Cancer
• Neurological Disorders
• Other Rare Cancers, Rare Diseases and Unmet Need

Submission Requirements & Due Date

• 22 January 2020: min data due
• 29 January 2020: applications submitted for internal review
• Please email mrff@adelaide.edu.au if you are considering applying for this scheme.
• See also: Submitting an Application to Research Services for Review

Further information

• General enquiries: mrff@adelaide.edu.au